Restylane Defyne is a type of hyaluronic acid dermal filler that is used to treat moderate to severe facial wrinkles and folds, such as nasolabial folds or marionette lines. Restylane Defyne is specifically designed to help smooth out deep wrinkles and restore a more youthful appearance to the face.

The hyaluronic acid in Restylane Defyne is formulated to provide support and flexibility to the skin, allowing it to move naturally without creating a stiff or unnatural look. This is especially important for areas of the face that are prone to movement, such as the mouth and jawline.

COMPOSITION

Cross-linked hyaluronic acid 20 mg/mL
Lidocaine hydrochloride 3 mg/mL

INDICATIONS FOR USE

Defyne is intended for injection into the mid to deep dermis for correction of severe facial wrinkles and folds such as nasolabial folds and marionette lines.

DURATION

Up to 12 months

FREE SHIPPING within Canada and the continential United States.

DISCLAIMER
Any medical device on this website is intended to be used exclusively by healthcare providers authorized to perform cosmetic injections.

RESTYLANE® Defyne

C$245.00

Quantity

Allergy to hyaluronic acid.

For additional information about the product, please refer to the information sheet provided inside the packaging, which contains important details regarding usage instructions, contraindications, and other pertinent information.
Dermal Distributor Outlet is committed to offering only the highest quality Class 3 medical devices (dermal fillers), ensuring that all products sold have undergone rigorous approval processes by Health Canada.

According to Canadian Law, any entity involved in the sale or distribution of Class 3 medical devices (dermal fillers), must possess a valid Medical Device Establishment License (MDEL) issued by Health Canada. The MDEL is a regulatory requirement designed to ensure the safety, quality, and effectiveness of medical devices available in the Canadian market.

The MDEL license demonstrates that the establishment has met the necessary criteria, including but not limited to quality management systems, risk management, adverse event reporting, and compliance with Good Manufacturing Practices (GMP). It signifies that the establishment has undergone the necessary assessments and inspections to comply with the regulatory standards set forth by Health Canada.

It is essential for companies engaged in the sale or distribution of Class 3 medical devices to obtain and maintain a valid MDEL license. Failure to do so may result in penalties, legal implications, and restrictions on the sale and distribution of medical devices within Canada.

Dermal Distributor Outlet, in collaboration with its manufacturing partners, holds valid Medical Device Establishment Licenses (MDELs) issued by Health Canada, demonstrating their commitment to regulatory compliance and ensuring the sale and distribution of authorized Class 3 medical devices.

Validation of MDEL and Health Canada compliance may be obtained accessing the link below:

Health Canada MDEL Listings

RESTYLANE DEFYNE

MANUFACTURER: Q-Med AB

Seminariegatan 21, Uppsala, SE 75228

MDEL (Manufacturer): 011362

MDEL (Dermal Distributor Outlet): 23703

RESTYLANE® Defyne

Contraindications

Package Contents

Health Canada Approved